Chevalier International Holdings Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:Chevalier International Holdings Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:MLINE7091497
◆発行会社(調査会社):MarketLine
◆発行日:2017年1月31日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:ビジネス・サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥18,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥37,800見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥56,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SummaryChevalier International Holdings Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on Chevalier International Holdings Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chevalier International Holdings Limited in the form of a SWOT analysis
- An in-depth view of the business model of Chevalier International Holdings Limited including a breakdown and examination of key business segments
- Intelligence on Chevalier International Holdings Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chevalier International Holdings Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of Chevalier International Holdings Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Chevalier International Holdings Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Chevalier International Holdings Limited’s business structure, strategy and prospects.

Key Highlights
Chevalier International Holdings Limited (CIHL) is a diversified investment holding company. Its portfolio of services includes construction, engineering, insurance, investment, property and hotel, lifestyle food and beverage, and information technology. It also provides automobiles, international trading and car dealership services. CIHL also designs, manufactures, installs, tests and maintains curtain walls, metal cladding, glass walls, skylights, louvers, aluminum windows and granite cladding. It sells automobiles, provides after sale services, procures parts and accessories, and repairs and paints damaged parts of cars. The company serves the needs of residential, commercial, industrial, institutional, infrastructure, and private and public sectors. Key projects of the company include: My Villa, Chateau Ermitas, Chevalier City, among others. The company has operations in China, Macau, Japan, Philippines, Vietnam, Canada, Singapore, the US, Australia and Thailand. CIHL is headquartered in Hong Kong.

【レポートの目次】

Company Snapshot
Chevalier International Holdings Limited: Company Overview
Chevalier International Holdings Limited: Overview and Key Facts
Chevalier International Holdings Limited: Overview
Chevalier International Holdings Limited: Key Facts
Chevalier International Holdings Limited: Key Employees
Chevalier International Holdings Limited: Key Employee Biographies
Chevalier International Holdings Limited: Major Products and Services
Chevalier International Holdings Limited: Company History
Chevalier International Holdings Limited: Management Statement
Chevalier International Holdings Limited: Locations and Subsidiaries
Chevalier International Holdings Limited: Key Competitors
Chevalier International Holdings Limited: Company Analysis
Chevalier International Holdings Limited: Business Description
Chevalier International Holdings Limited: SWOT Analysis
Chevalier International Holdings Limited: SWOT Overview
Chevalier International Holdings Limited: Strengths
Chevalier International Holdings Limited: Weaknesses
Chevalier International Holdings Limited: Opportunities
Chevalier International Holdings Limited: Threats
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: Chevalier International Holdings Limited: Key Facts
Table 2: Chevalier International Holdings Limited: Key Employees
Table 4: Chevalier International Holdings Limited: Key Competitors

★海外企業調査レポート[Chevalier International Holdings Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnerWorks Inc.:企業の戦略的SWOT分析
    EnerWorks Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • The Valspar Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Valspar Corporation Mergers …
  • Brother Industries, Ltd.:企業の戦略・SWOT・財務分析
    Brother Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Brother Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tillotts Pharma AG(製薬・医療分野):企業M&A動向
    Summary Tillotts Pharma AG (Tillotts) is a specialty pharmaceutical company. It is involved in the development, in and out-licensing and marketing of innovative pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products target the treatment of v …
  • TotipotentSC USA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TotipotentSC USA Mergers and Ac …
  • Energy Resources Conservation and Development Commission:企業の戦略的SWOT分析
    Energy Resources Conservation and Development Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • Ionian Hotel Enterprises S.A.:企業の戦略・SWOT・財務分析
    SummaryIonian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):企業財務及び戦略的SWOT分析
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a pharmaceutical company that develops circulatory, digestive, respiratory, central and peripheral nervous system medicines. The company’s products comprise acarbose tablets, alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacam …
  • MI Bioresearch Inc-医療機器分野:企業M&A・提携分析
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous m …
  • Korea Midland Power Co., Ltd.:企業のM&A・提携動向(エネルギー分野)
    Summary Korea Midland Power Co., Ltd. (Komipo) is an electric utility that generates electricity from coal, solar, wind, bio fuel, and other sources. The company own and operate steam, internal combustion and combined cycle thermal power generation, pumped-storage, and renewable energy power plants. …
  • CNTEE Transelectrica S.A.:発電所・企業SWOT分析
    CNTEE Transelectrica S.A. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Specialised Therapeutics Australia Pty Ltd:企業のM&A・提携動向(医療分野)
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a bio-pharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes Abraxane, Gliolan, Oncotype DX, Iclusig, Oncotype DX Prostate and Aloxi. Its pipeline …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Canada Zinc Metals Corp.:企業の戦略・SWOT・財務分析
    SummaryCanada Zinc Metals Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Copalis:戦略・SWOT・企業財務分析
    Copalis - Strategy, SWOT and Corporate Finance Report Summary Copalis - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • JBS S.A.:企業のM&A・事業提携・投資動向
    JBS S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JBS S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Food Empire Holdings Limited:企業の戦略・SWOT・財務情報
    Food Empire Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Food Empire Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Primark Stores Limited:企業の戦略・SWOT・財務分析
    SummaryPrimark Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆